0.20 TWD
9.15 M TWD
117.87 M TWD
About PET PHARM BIOTECH CO LTD
Sector
CEO
Liang Kuang Lin
Headquarters
New Taipei City
Website
Founded
2011
ISIN
TW0007762007
FIGI
BBG01NT5CGH8
PET Pharm Biotech Co., Ltd. manufactures molecular imaging medicines. Its products include Naolixi Injection, FDG Fluodeoxy glucose Injection, Sodium fluoride injection and Radioactive sodium iodide capsules. The company was founded on October 01, 2011 and is headquartered in New Taipei city, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7762 is 40.80 TWD — it has decreased by −1.09% in the past 24 hours. Watch PET PHARM BIOTECH CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange PET PHARM BIOTECH CO LTD stocks are traded under the ticker 7762.
7762 stock has fallen by −0.49% compared to the previous week, the month change is a −1.57% fall, over the last year PET PHARM BIOTECH CO LTD has showed a 22.96% increase.
7762 reached its all-time high on Nov 7, 2024 with the price of 45.05 TWD, and its all-time low was 27.25 TWD and was reached on Aug 5, 2024. View more price dynamics on 7762 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7762 stock is 3.47% volatile and has beta coefficient of 0.19. Track PET PHARM BIOTECH CO LTD stock price on the chart and check out the list of the most volatile stocks — is PET PHARM BIOTECH CO LTD there?
Yes, you can track PET PHARM BIOTECH CO LTD financials in yearly and quarterly reports right on TradingView.
7762 net income for the last half-year is 3.37 M TWD, while the previous report showed 4.28 M TWD of net income which accounts for −21.32% change. Track more PET PHARM BIOTECH CO LTD financial stats to get the full picture.
As of Dec 31, 2024, the company has 36.00 employees. See our rating of the largest employees — is PET PHARM BIOTECH CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PET PHARM BIOTECH CO LTD EBITDA is 22.86 M TWD, and current EBITDA margin is 20.65%. See more stats in PET PHARM BIOTECH CO LTD financial statements.
Like other stocks, 7762 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PET PHARM BIOTECH CO LTD stock right from TradingView charts — choose your broker and connect to your account.